Sigma Planning Corp’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,389
| Closed | -$54.8K | – | 1348 |
|
|
2025
Q1 | $54.8K | Sell |
17,389
-6,057
| -26% | -$29.5K | ﹤0.01% | 1181 |
|
|
2024
Q4 | $158K | Buy |
23,446
+10,054
| +75% | +$91.6K | 0.01% | 1111 |
|
|
2024
Q3 | $165K | Buy |
13,392
+5,576
| +71% | +$84.9K | 0.01% | 1147 |
|
|
2024
Q2 | $178K | Buy |
7,816
+1,602
| +26% | +$54.4K | 0.01% | 1105 |
|
|
2024
Q1 | $309K | Buy |
6,214
+3,698
| +147% | +$212K | 0.01% | 949 |
|
|
2023
Q4 | $192K | Sell |
2,516
-2,344
| -48% | -$182K | 0.02% | 785 |
|
|
2023
Q3 | $408K | Buy |
+4,860
| New | +$573K | 0.02% | 796 |
|
|
2023
Q2 | – | Sell |
-3,210
| Closed | -$925K | – | 1379 |
|
|
2023
Q1 | $925K | Buy |
3,210
+831
| +35% | +$241K | 0.03% | 545 |
|
|
2022
Q4 | $621K | Buy |
2,379
+380
| +19% | +$102K | 0.02% | 680 |
|
|
2022
Q3 | $535K | Buy |
1,999
+128
| +7% | +$44.1K | 0.02% | 706 |
|
|
2022
Q2 | $625K | Buy |
1,871
+113
| +6% | +$54.1K | 0.02% | 666 |
|
|
2022
Q1 | $1.08M | Buy |
1,758
+497
| +39% | +$275K | 0.03% | 507 |
|
|
2021
Q4 | $766K | Buy |
1,261
+122
| +11% | +$115K | 0.02% | 659 |
|
|
2021
Q3 | $1.12M | Buy |
1,139
+294
| +35% | +$368K | 0.03% | 504 |
|
|
2021
Q2 | $1.26M | Buy |
845
+120
| +17% | +$261K | 0.04% | 472 |
|
|
2021
Q1 | $1.95M | Buy |
725
+80
| +12% | +$159K | 0.06% | 315 |
|
|
2020
Q4 | $1.27M | Buy |
645
+72
| +13% | +$169K | 0.04% | 383 |
|
|
2020
Q3 | $1.55M | Buy |
573
+22
| +4% | +$54.9K | 0.06% | 300 |
|
|
2020
Q2 | $1.56M | Buy |
551
+16
| +3% | +$51.6K | 0.07% | 282 |
|
|
2020
Q1 | $1.43M | Buy |
535
+8
| +2% | +$23.9K | 0.09% | 246 |
|
|
2019
Q4 | $1.34M | Buy |
527
+20
| +4% | +$26.1K | 0.06% | 335 |
|
|
2019
Q3 | $476K | Buy |
507
+20
| +4% | +$22.8K | 0.02% | 594 |
|
|
2019
Q2 | $572K | Buy |
+487
| New | +$448K | 0.03% | 509 |
|
Other funds holding APTO
DS
GG
TWC
CSC
Sigma Planning Corp's APTO Position: Q2 2025 in Review
Sigma Planning Corp sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 17,389 shares — an estimated $54.8K sold.
Sigma Planning Corp first reported a position in APTO in Q2 2019 and held it in 23 quarters. The position peaked at $1.95M in Q1 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.
- Sigma Planning Corp reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
- Sigma Planning Corp sold 17,389 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $54.8K.
- Sigma Planning Corp first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 23 quarters.
- Sigma Planning Corp's Aptose Biosciences, Inc. position peaked at $1.95M in Q1 2021.
- 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.
Based on Sigma Planning Corp's 13F filing for Q2 2025, filed 5 Aug 2025.